Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
0.487
-0.014 (-2.72%)
Nov 7, 2024, 4:00 PM EST - Market closed

Eyenovia Statistics

Total Valuation

Eyenovia has a market cap or net worth of $42.03 million. The enterprise value is $56.57 million.

Market Cap 42.03M
Enterprise Value 56.57M

Important Dates

The next confirmed earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

Eyenovia has 86.38 million shares outstanding. The number of shares has increased by 28.63% in one year.

Current Share Class 86.38M
Shares Outstanding 86.38M
Shares Change (YoY) +28.63%
Shares Change (QoQ) +13.98%
Owned by Insiders (%) 13.50%
Owned by Institutions (%) 7.41%
Float 68.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 6.89
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1,801.19
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.46

Current Ratio 0.46
Quick Ratio 0.17
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -13.25

Financial Efficiency

Return on equity (ROE) is -914.66% and return on invested capital (ROIC) is -112.46%.

Return on Equity (ROE) -914.66%
Return on Assets (ROA) -92.94%
Return on Capital (ROIC) -112.46%
Revenue Per Employee $551
Profits Per Employee -$654,064
Employee Count 57
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -62.71% in the last 52 weeks. The beta is 1.75, so Eyenovia's price volatility has been higher than the market average.

Beta (5Y) 1.75
52-Week Price Change -62.71%
50-Day Moving Average 0.51
200-Day Moving Average 0.93
Relative Strength Index (RSI) 44.01
Average Volume (20 Days) 858,035

Short Selling Information

The latest short interest is 2.29 million, so 2.65% of the outstanding shares have been sold short.

Short Interest 2.29M
Short Previous Month 3.29M
Short % of Shares Out 2.65%
Short % of Float 3.33%
Short Ratio (days to cover) 2.97

Income Statement

In the last 12 months, Eyenovia had revenue of $31,405 and -$37.28 million in losses. Loss per share was -$0.79.

Revenue 31,405
Gross Profit -5.53M
Operating Income -35.94M
Pretax Income -32.44M
Net Income -37.28M
EBITDA -34.80M
EBIT -35.94M
Loss Per Share -$0.79
Full Income Statement

Balance Sheet

The company has $2.30 million in cash and $15.66 million in debt, giving a net cash position of -$13.36 million or -$0.15 per share.

Cash & Cash Equivalents 2.30M
Total Debt 15.66M
Net Cash -13.36M
Net Cash Per Share -$0.15
Equity (Book Value) -2.37M
Book Value Per Share -0.04
Working Capital -8.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.23 million and capital expenditures -$885,248, giving a free cash flow of -$31.11 million.

Operating Cash Flow -30.23M
Capital Expenditures -885,248
Free Cash Flow -31.11M
FCF Per Share -$0.36
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -114,446.45%
Pretax Margin -118,712.53%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -341,869.79%

Dividends & Yields

Eyenovia does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -28.63%
Shareholder Yield -28.63%
Earnings Yield -84.58%
FCF Yield -70.59%

Analyst Forecast

The average price target for Eyenovia is $12.00, which is 2,366.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.00
Price Target Difference 2,366.09%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 681.35%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Eyenovia has an Altman Z-Score of -17.33 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -17.33
Piotroski F-Score 2